Volume 19, Number 4—April 2013
Letter
West Nile Virus Infection in Belgian Traveler Returning from Greece
Lieselotte Cnops
, Anna Papa, Frideriki Lagra, Philippe Weyers, Kathleen Meersman, Nicolas Patsouros, and Marjan Van Esbroeck
, Anna Papa, Frideriki Lagra, Philippe Weyers, Kathleen Meersman, Nicolas Patsouros, and Marjan Van Esbroeck
Table
Laboratory results confirming WNV infection of 73-year-old woman, Greece, 2012*†
| Sample | Date | RT-PCR (Ct value) | WNV ELISA IgM (ratio) | WNV ELISA IgG (ratio) | Flavi IFAT IgM | Flavi IFAT IgG |
|---|---|---|---|---|---|---|
| Serum | Aug 15 | Positive (45.47) | Positive (25) | Negative | ND | ND |
| CSF | Sep 3 | ND | Positive (5.16) | Positive (2.21) | ND | ND |
| Serum | Sep 6 | Positive (42.87)‡ | Positive (4.76) | Positive (2.63) | WNV positive | WNV positive§ |
*WNV, West Nile virus; RT-PCR, reverse transcription PCR; Ct, cycle threshold; Flavi, flavivirus; IFAT, indirect fluorescent antibody technique; ND, not done; CSF, cerebrospinal fluid.
†The ELISA is positive if ratio >1.1 for IgM and >1.5 for IgG. The cutoff value for IFAT is 1/10 for both IgG and IgM.
‡Sequencing revealed a 116-bp sequence perfectly matched to the WNV amplicon and is highly suggestive for WNV lineage 2 on the basis of the presence of 2 specific nucleotides.
§Strongest signal for WNV, weak signal for other flaviviruses (Japanese encephalitis virus, dengue viruses 1–4, yellow fever virus).
Page created: March 13, 2013
Page updated: March 13, 2013
Page reviewed: March 13, 2013
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.
Content Credential